UNICK FIX-A-FORM AND PRINTERS | ELDER PHARMA | UNICK FIX-A-FORM AND PRINTERS/ ELDER PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -1.0 | - | View Chart |
P/BV | x | 1.1 | 0.1 | 1,137.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS ELDER PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
ELDER PHARMA Jun-14 |
UNICK FIX-A-FORM AND PRINTERS/ ELDER PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 380 | 15.5% | |
Low | Rs | 32 | 188 | 16.8% | |
Sales per share (Unadj.) | Rs | 120.5 | 489.2 | 24.6% | |
Earnings per share (Unadj.) | Rs | 4.1 | -3.2 | -128.4% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 14.4 | 77.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 376.5 | 14.3% | |
Shares outstanding (eoy) | m | 5.49 | 20.54 | 26.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0.6 | 64.7% | |
Avg P/E ratio | x | 11.1 | -89.3 | -12.4% | |
P/CF ratio (eoy) | x | 4.0 | 19.7 | 20.5% | |
Price / Book Value ratio | x | 0.8 | 0.8 | 111.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 5,832 | 4.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 2,179 | 4.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 10,048 | 6.6% | |
Other income | Rs m | 5 | 257 | 2.0% | |
Total revenues | Rs m | 667 | 10,305 | 6.5% | |
Gross profit | Rs m | 88 | 2,921 | 3.0% | |
Depreciation | Rs m | 39 | 361 | 10.8% | |
Interest | Rs m | 24 | 2,756 | 0.9% | |
Profit before tax | Rs m | 30 | 60 | 49.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 125 | 6.0% | |
Profit after tax | Rs m | 22 | -65 | -34.3% | |
Gross profit margin | % | 13.3 | 29.1 | 45.6% | |
Effective tax rate | % | 25.0 | 209.1 | 12.0% | |
Net profit margin | % | 3.4 | -0.6 | -521.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 9,240 | 3.3% | |
Current liabilities | Rs m | 287 | 9,998 | 2.9% | |
Net working cap to sales | % | 2.1 | -7.5 | -28.2% | |
Current ratio | x | 1.0 | 0.9 | 113.5% | |
Inventory Days | Days | 4 | 128 | 3.0% | |
Debtors Days | Days | 72,349,839 | 602 | 12,021,572.0% | |
Net fixed assets | Rs m | 402 | 13,642 | 2.9% | |
Share capital | Rs m | 55 | 206 | 26.7% | |
"Free" reserves | Rs m | 241 | 7,528 | 3.2% | |
Net worth | Rs m | 296 | 7,733 | 3.8% | |
Long term debt | Rs m | 89 | 4,889 | 1.8% | |
Total assets | Rs m | 705 | 22,882 | 3.1% | |
Interest coverage | x | 2.3 | 1.0 | 220.6% | |
Debt to equity ratio | x | 0.3 | 0.6 | 47.4% | |
Sales to assets ratio | x | 0.9 | 0.4 | 213.6% | |
Return on assets | % | 6.6 | 11.8 | 55.7% | |
Return on equity | % | 7.6 | -0.8 | -896.9% | |
Return on capital | % | 14.0 | 22.3 | 62.6% | |
Exports to sales | % | 0 | 3.1 | 0.0% | |
Imports to sales | % | 0 | 0.4 | 0.0% | |
Exports (fob) | Rs m | NA | 307 | 0.0% | |
Imports (cif) | Rs m | NA | 43 | 0.0% | |
Fx inflow | Rs m | 0 | 307 | 0.0% | |
Fx outflow | Rs m | 0 | 125 | 0.0% | |
Net fx | Rs m | 0 | 181 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 11,754 | 0.4% | |
From Investments | Rs m | -27 | -561 | 4.8% | |
From Financial Activity | Rs m | -16 | -6,762 | 0.2% | |
Net Cashflow | Rs m | 0 | 5,466 | 0.0% |
Indian Promoters | % | 71.6 | 25.3 | 282.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 24.0 | 1.9% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 74.7 | 38.1% | |
Shareholders | 1,622 | 31,548 | 5.1% | ||
Pledged promoter(s) holding | % | 0.0 | 77.6 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | Elder Pharma | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | 4.97% | -0.26% |
1-Month | 21.23% | 21.21% | -0.74% |
1-Year | 56.84% | -64.54% | 29.95% |
3-Year CAGR | 31.01% | -51.65% | 10.57% |
5-Year CAGR | 20.58% | -37.46% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the Elder Pharma share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of Elder Pharma the stake stands at 25.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of Elder Pharma.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of Elder Pharma.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.